Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis

QR Code

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis

Aim. To study the efficacy and safety of mycophenolate mofetil (MM) in combination with corticosteroids in the treatment of lymphocytic myocarditis in comparison with a standard combination of corticosteroids and azathioprine.Material and methods. The study included 46 patients aged 18 years and old...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. S. Rud, O. V. Blagova, E. A. Kogan, V. M. Novosadov, A. Yu. Zaitsev, V. P. Sedov, V. A. Zaydenov, A. G. Kupriyanova, V. V. Kadochnikova, A. E. Donnikov, A. V. Nedostup
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-12-01
Series:	Российский кардиологический журнал
Subjects:	lymphocytic myocarditis endomyocardial biopsy parvovirus b19 immunosuppressive therapy corticosteroids azathioprine mycophenolate mofetil treatment
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4650
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of myocarditis therapy depending on the diagnosis approach (with or without myocardial biopsy)
by: O. V. Blagova, et al.
Published: (2021-05-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives
by: Khalid Aljohani, et al.
Published: (2025-05-01)

The ability of Mycophenolate Mofetil to induce chromosome aberration and DNA damage in Mus Musculus Mice
by: RUIDA WATHEQ NEAMA, et al.
Published: (2019-12-01)

Mycophenolate mofetil versus cyclophosphamide, in combination with prednisolone for lupus nephritis induction treatment: Findings from a prospective observational study
by: Rakhesh LR, et al.
Published: (2025-07-01)

Efficacy and Long-Term Outcomes of Tacrolimus versus Cyclophosphamide and Mycophenolate Mofetil in the Management of Pediatric IgA Vasculitis Nephritis: A Cohort Study in Single-Center
by: Han Y, et al.
Published: (2025-07-01)

COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II)
by: O. V. Blagova, et al.
Published: (2020-11-01)

Herpetic gingivostomatitis mimicking Stevens-Johnson syndrome in an immunosuppressed adolescent with idiopathic chorioretinitis
by: Aim-On Saengsirinavin, et al.
Published: (2025-01-01)

Value of Azathioprine in Controlling Vitiligo Activity
by: Rania El-Husseiny, et al.
Published: (2025-07-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics)
by: O. V. Blagova, et al.
Published: (2015-09-01)

USE OF MYCOPHENOLATE MOPHETYL IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: S.I. Valiyeva,, et al.
Published: (2006-03-01)

DCMP AS A CLINICAL SYNDROME: RESULTS OF NOSOLOGICAL DIAGNOSTICS WITH MYOCARDIAL BIOPSY AND DIFFERENTIATED TREATMENT IN VIRUS-POSITIVE AND VIRUS-NEGATIVE PATIENTS
by: O. V. Blagova, et al.
Published: (2016-01-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment)
by: O. V. Blagova, et al.
Published: (2015-09-01)

Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01)

Clinical Profile of Pediatric Patients with Steroid-resistant Nephrotic Syndrome Treated by Cyclophosphamide, Cyclosporin A, Mycophenolate Mofetile and Tacrolimus in Hasan Sadikin General Hospital
by: Ahmedz Widiasta, et al.
Published: (2024-03-01)

Rituximab versus azathioprine in maintenance therapy of patients with granulomatosis with polyangiitis
by: Samira Alesaeidi, et al.
Published: (2025-06-01)

Correction of Structural Changes in Thymus by <i>Gentiana algida</i> Pall Extract at Experimental Azathioprine Immunosuppression
by: V. B. Khobrakova, et al.
Published: (2020-11-01)

MULTISPIRAL COMPUTED TOMOGRAPHY VERSUS MYOCARDIAL BIOPSY IN DIAGNOSTICS OF YOCARDITIS AND PROGNOSIS EVALUATION OF DILATION CARDIOMYOPATHY SYNDROME
by: I. N. Alieva, et al.
Published: (2017-02-01)

PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine
by: Laura L. Daniel, et al.
Published: (2025-06-01)

Pharmacoeconomic analysis of using drugs containing mycophenolic acid in kidney transplant recipients in the context of domestic pharmaceutical market
by: V. N. Lesovoy, et al.
Published: (2015-08-01)

A comparative study of pharmacokinetics of coated tablets of mycophenolic acid
by: A. L. Khokhlov, et al.
Published: (2016-11-01)

Clinical Profile and Outcomes of COVID-19 in Renal Transplant Recipients
by: Mohit Mahajan, et al.
Published: (2021-12-01)

MYOCARDITIS AS A LEGITIMATE PHENOMENON IN NON-COMPACTION MYOCARDIUM: DIAGNOSTICS, MANAGEMENT AND INFLUENCE ON OUTCOMES
by: O. V. Blagova, et al.
Published: (2018-03-01)

CONTEMPORARY MASKS OF THE MYOCARDITIS (FROM CLINICAL SIGNS TO DIAGNOSIS)
by: O. V. Blagova, et al.
Published: (2014-05-01)

Influence of probiotics and deoxycholate on azathioprine transport in the PAMPA model: insights into pharmacomicrobiomics and interindividual variability in drug response
by: Maja Đanić, et al.
Published: (2025-06-01)

Clinical Pharmacokinetics of Triple Immunosuppression Scheme in Kidney Transplant (Tacrolimus, Mycophenolate Mofetil and Corticosteroids)
by: Luisa, Robles Piedras Ana, et al.
Published: (2011)

Juvenile Localized Scleroderma. Questions of Treatment
by: Rinat K. Raupov, et al.
Published: (2020-08-01)

Post-COVID Versus Non-COVID Myocarditis: Comparison of Morphological Activity, Toll-like Receptor Distribution and Responses to Immunosuppressive Therapy
by: Olga V. Blagova, et al.
Published: (2025-06-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01)

Infectious-immune pericarditis: clinical assessment, diagnostics, and differentiated baseline therapy with hydroxychloroquine
by: O. V. Blagova, et al.
Published: (2020-12-01)

Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman
by: O. V. Blagova, et al.
Published: (2020-05-01)

MYOCARDIAL INFARCTION AS TYPICAL PRESENTATION OF NONCOMPACTION CARDIOMYOPATHY
by: O. V. Blagova, et al.
Published: (2016-10-01)

Should mycophenolate mofetil be first-line treatment in autoimmune hepatitis?
by: J.A. Torres-Díaz, et al.
Published: (2025-04-01)

Infective and nonbacterial thrombotic endocarditis in patients with post-COVID-19 viral-immune myocarditis
by: O. V. Blagova, et al.
Published: (2022-09-01)

Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias
by: O. V. Blagova, et al.
Published: (2021-11-01)

MYOCARDIAL BIOPSY IN GENERAL CARE CLINIC: PATIENTS SELECTION, THE RESULTS, SIGNIFICANCE FOR TREATMENT STRATEGY
by: O. V. Blagova, et al.
Published: (2015-05-01)

Parvovirus B19 infection prevalens in North-West Russia
by: A. Y. Antipova, et al.
Published: (2014-09-01)

Autoimmune hepatitis: new in diagnostics, a pathogenesis and treatment
by: Ye. N. Shirokova, et al.
Published: (2012-09-01)

PRIMARY (GENETICALLY DETERMINED) DILATION CARDIOMYOPATHY IN A PATIENT WITH NOVEL MUTATION OF LAMIN GENE: CLINICAL AND MORPHOLOGICAL MANAGEMENT
by: O. V. Blagova, et al.
Published: (2017-08-01)